PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pathology and Laboratory Medicine, Sinai Health System, Toronto, Canada; University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada.\', \'Department of Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, Newfoundland, Canada.\', \'University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada; William Osler Health System, Brampton, Canada.\', \'Dynacare, Brampton, Canada.\', \'Clinical Biochemistry, Maisonneuve-Rosemont Hospital, Optilab-CHUM Laboratory Network, Montreal, Canada; Biochemistry, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Canada.\', \'Fraser Health Authority, Vancouver, Canada; Pathology and Laboratory Medicine, University of British Columbia, Canada.\', \'Pathology and Laboratory Medicine, London Health Sciences Center, London, Canada; Pathology and Laboratory Medicine, University of Western Ontario, London, Canada.\', \'Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.\', \'University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada; University of Toronto, Medicine, Toronto, Canada; University Health Network/Sinai Health Department of Microbiology, Toronto, Canada.\', \'Eastern Ontario Regional Laboratory Association, Canada; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.\', \'Lifelabs, Toronto, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0009-9120(21)00151-X10.1016/j.clinbiochem.2021.05.010
?:doi
?:hasPublicationType
?:journal
  • Clinical biochemistry
is ?:pmid of
?:pmid
?:pmid
  • 34048776
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 95
?:title
  • Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all